cancer research Fundamentals Explained
ArticleOpen Access18 Apr 2024 An oncolytic virus offering tumor-irrelevant bystander T mobile epitopes induces anti-tumor immunity and potentiates cancer immunotherapy Ye and colleagues display that an oncolytic virus that delivers tumor-irrelevant bystander T cell epitopes to tumor cells can exploit the considerable inhabitants of bystander T cell